Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Cancer Trials Ireland
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Mayo Clinic
European Myeloma Network B.V.
Dana-Farber Cancer Institute
Celgene
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
M.D. Anderson Cancer Center
University of Arkansas
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Arkansas
University of Arkansas
University of Arkansas
City of Hope Medical Center
European Myeloma Network B.V.
Amsterdam UMC, location VUmc
University of Leeds
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
University of Leeds
Celyad Oncology SA
Allogene Therapeutics